Results 121 to 130 of about 1,329 (197)

Budget impact analysis of cabergoline for medical treatment of Cushing's disease in Brazil. [PDF]

Arch Endocrinol Metab
Silva LFO, Galendi JSC, Martins MRA, Nogueira VDSN.   +3 more
europepmc   +1 more source

8β-Carbobenzyloxyaminomethyl-1,6-dimethyl-10α-ergoline [PDF]

Journal of Pharmacy and Pharmacology, 1965
M. B. Nobili, A. H. Glässer, R. Silvestri, C. Beretta   +3 more
openaire   +1 more source

Psychedelics: preclinical insights provide directions for future research. [PDF]

Neuropsychopharmacology
Gumpper RH, Roth BL.
europepmc   +1 more source

Faculty Opinions recommendation of High-Resolution Genetics Identifies the Lipid Transfer Protein Sec14p as Target for Antifungal Ergolines.

, 2017
Karin Römisch
openalex   +2 more sources

Psychedelics: Safety and Efficacy. [PDF]

Int J Environ Res Public Health
Miller N.
europepmc   +1 more source

Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money. [PDF]

Annu Rev Psychol
Humphreys K, Todd Korthuis P, Stjepanović D, Hall W.   +3 more
europepmc   +1 more source

Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology

, 2023
Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML.   +6 more
europepmc   +1 more source

Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism. [PDF]

Neuropsychopharmacology
Mitchell JM, Anderson BT.
europepmc   +1 more source

Uncovering the unique characteristics of different groups of 5-HT_5AR ligands with reference to their interaction with the target protein. [PDF]

Pharmacol Rep
Kordylewski SK, Bugno R, Bojarski AJ, Podlewska S.   +3 more
europepmc   +1 more source